Welcome to the CCI and Anonymization Survey

Your insights are invaluable as we explore the challenges, methodologies, and adaptations related to the redaction of Company Confidential Information (CCI) and anonymization in clinical trial documents.
.
⏱️ Estimated Time: Approximately 5 minutes to complete.
.
Your responses are anonymous. However, if you wish to receive an advance copy of the survey results and our whitepaper, you can provide your email address at the end of the survey.
.
Your participation will contribute to our understanding of the industry's current practices and help shape future strategies and approaches in CCI redaction and anonymization.

Thank you for your valuable input!

------------------------------------------------------------------

Question Title

* 1. What is your organization's top concern regarding potential risks to anonymized patient data?

(Select all that apply)

Question Title

* 2. How confident are you in your organization's current process for patient data anonymization in CTIS submissions?

0 - Not at all confident 100 - Extremely confident
Clear
i We adjusted the number you entered based on the slider’s scale.

Question Title

* 3. Which anonymization methodologies does your organization primarily employ when preparing documents and data for CTIS submission?

(Select all that apply)

Question Title

* 4. How does your organization ensure the quality and accuracy of anonymized data when using complex methods such as permutation and perturbation?

(Select all that apply)

Question Title

* 5. What is your organization's primary method for anonymizing patient and other personal information from documents and data submitted to CTIS?

(Select all that apply)

Question Title

* 6. What challenges does your organization encounter when responding to RFIs about the anonymized documents and data for CTIS submissions?

(Select all that apply)

Question Title

* 7. Please rate your agreement with the following statement:

"My organization is comfortable navigating and implementing different anonymization methodologies based on the specific requirements of CTIS submissions."

0 - Strongly Disagree 100 - Strongly Agree
Clear
i We adjusted the number you entered based on the slider’s scale.

Question Title

* 8. Does your organization provide regular training on patient data anonymization procedures to the relevant staff?

Question Title

* 9. What are your organization's main challenges in redacting Company Confidential Information (CCI)?

(Select all that apply)

Question Title

* 10. How is your organization adapting its redaction processes to evolving data privacy regulations and CTIS requirements?

(Select all that apply)

Question Title

* 11. How does your organization verify the effectiveness of redactions in protecting CCI?

(Select all that apply)

Question Title

* 12. If using automated redaction tools, how effectively have they maintained the confidentiality of sensitive information?

0 - Not effective at all 100 - Extremely effective
Clear
i We adjusted the number you entered based on the slider’s scale.

Question Title

* 13. What are the primary methods used by your organization for redacting CCI from documents submitted to CTIS?

(Select all that apply)

Question Title

* 14. How does your organization handle requests for information (RFIs) from reporting member states (RMS) or member states concerned (MSC) if they push back on redacting CCI?

Question Title

* 15. How does your organization monitor and update the protection of CCI throughout the trial?

Question Title

* 16. Do you have any other thoughts, suggestions, or concerns about anonymization or CCI redaction?

Question Title

* 17. Please provide your email if you would like an advance copy of the survey results and the whitepaper (Optional).

T